Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP734854.RAdlb7z1HIymALv1uU40h1UXn1C8QknDEJ_CVpHyFF1Bs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP734854.RAdlb7z1HIymALv1uU40h1UXn1C8QknDEJ_CVpHyFF1Bs130_assertion type Assertion NP734854.RAdlb7z1HIymALv1uU40h1UXn1C8QknDEJ_CVpHyFF1Bs130_head.
- NP734854.RAdlb7z1HIymALv1uU40h1UXn1C8QknDEJ_CVpHyFF1Bs130_assertion description "[EphA2 targeted siRNA was tested in combination with either FAK or Src targeted siRNA using DOPC nanoliposomes in orthotopic models of ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734854.RAdlb7z1HIymALv1uU40h1UXn1C8QknDEJ_CVpHyFF1Bs130_provenance.
- NP734854.RAdlb7z1HIymALv1uU40h1UXn1C8QknDEJ_CVpHyFF1Bs130_assertion evidence source_evidence_literature NP734854.RAdlb7z1HIymALv1uU40h1UXn1C8QknDEJ_CVpHyFF1Bs130_provenance.
- NP734854.RAdlb7z1HIymALv1uU40h1UXn1C8QknDEJ_CVpHyFF1Bs130_assertion SIO_000772 19395869 NP734854.RAdlb7z1HIymALv1uU40h1UXn1C8QknDEJ_CVpHyFF1Bs130_provenance.
- NP734854.RAdlb7z1HIymALv1uU40h1UXn1C8QknDEJ_CVpHyFF1Bs130_assertion wasDerivedFrom befree-2016 NP734854.RAdlb7z1HIymALv1uU40h1UXn1C8QknDEJ_CVpHyFF1Bs130_provenance.
- NP734854.RAdlb7z1HIymALv1uU40h1UXn1C8QknDEJ_CVpHyFF1Bs130_assertion wasGeneratedBy ECO_0000203 NP734854.RAdlb7z1HIymALv1uU40h1UXn1C8QknDEJ_CVpHyFF1Bs130_provenance.